Deepa M. Gopal, MD, MS
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Cardiovascular Medicine

MD, University of Missouri
MS, Emory University
BA, University of Missouri

Deepa Gopal, MD, is an Assistant Professor of Cardiovascular Medicine at the Chobanian and Avedisian School of Medicine and a Staff Cardiologist at the Boston Medical Center. Before being appointed as an Instructor, Dr. Gopal completed a five year fellowship at Boston University, during which she received a teaching award. Currently, she is on the Cardiology Fellowship Selection Committee at the university. Outside the university she is a member of four societies including the American College of Cardiology and the Heart Failure Society of America.

Boston University
Whitaker Cardiovascular Institute

Boston University
Amyloidosis Center

ALLAY-HF: Safety and Efficacy of the Alleviant System for No-Implant Interatrial Shunt Creation in Patients with Chronic Heart Failure
06/13/2023 - 06/13/2028 (PI)
Alleviant Medical, Inc.

Cardiopulmonary Exercise MRI in Heart Failure with Preserved Ejection Fraction
09/01/2021 - 08/31/2026 (PI)
Beth Israel Deaconess Medical Center National Heart, Lung

CLCZ696DUS01: “A multicenter, randomized, double-blind, doubledummy, parallel group, active controlled 8-week study to evaluate the effect of sacubitril/valsartan (LCZ696) versus valsartan on changes in NT-proBNP and safety and tolerability of in-hospital
05/31/2022 - 05/31/2025 (PI)
Novartis Pharma Corp

CARS Registry
09/01/2021 - 08/31/2023 (PI)
Cedars-Sinai Medical Center

Cardiac Phenotyping to Identify Preclinical Heart Failure in Metabolic Syndrome
07/01/2017 - 06/30/2023 (PI)
American Heart Association/AHA

Study to evaluate the efficacy and safety of LCZ696
09/15/2014 - 08/31/2021 (PI)
Novartis Pharma Corp


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Shah RV, Hwang SJ, Murthy VL, Zhao S, Tanriverdi K, Gajjar P, Duarte K, Schoenike M, Farrell R, Brooks LC, Gopal DM, Ho JE, Girerd N, Vasan RS, Levy D, Freedman JE, Lewis GD, Nayor M. Proteomics and Precise Exercise Phenotypes in Heart Failure With Preserved Ejection Fraction: A Pilot Study. J Am Heart Assoc. 2023 Oct 27; e029980.View Related Profiles. PMID: 37889181
  2. Gustine JN, Staron A, Mendelson L, Joshi T, Gopal DM, Siddiqi OK, Ruberg FL, Sanchorawala V. Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis. Blood Adv. 2023 Oct 24; 7(20):6080-6091.View Related Profiles. PMID: 37581513
  3. Li Y, Gray A, Xue L, Farb MG, Ayalon N, Andersson C, Ko D, Benjamin EJ, Levy D, Vasan RS, Larson MG, Rong J, Xanthakis V, Liu C, Fetterman JL, Gopal DM. Metabolomic Profiles, Ideal Cardiovascular Health, and Risk of Heart Failure and Atrial Fibrillation: Insights From the Framingham Heart Study. J Am Heart Assoc. 2023 Jun 20; 12(12):e028022.View Related Profiles. PMID: 37301766; PMCID: PMC10356055; DOI: 10.1161/JAHA.122.028022;
  4. Moreira JD, Haack K, White V, Bates ML, Gopal DM, Roepke TA. Importance of survey demographic questions to foster inclusion in medicine and research and reduce health inequities for LGBTQIA2S+ individuals. Am J Physiol Heart Circ Physiol. 2023 Jun 01; 324(6):H856-H862.View Related Profiles. PMID: 37115629
  5. Lui JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, Trojanowski MA, Bujor AM, Gopal DM, Wiener RS, LaValley MP, Klings ES. Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovasc Drugs Ther. 2023 Jan 20.View Related Profiles. PMID: 36662449
  6. Lui JK, Gillmeyer KR, Sangani RA, Smyth RJ, Gopal DM, Trojanowski MA, Bujor AM, Soylemez Wiener R, LaValley MP, Klings ES. A Multimodal Prediction Model for Diagnosing Pulmonary Hypertension in Systemic Sclerosis. Arthritis Care Res (Hoboken). 2023 Jul; 75(7):1462-1468.View Related Profiles. PMID: 35678779; PMCID: PMC9732142; DOI: 10.1002/acr.24969;
  7. Lui JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, Trojanowski MA, Bujor AM, Gopal DM, Wiener RS, LaValley MP, Klings ES. Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovasc Drugs Ther. 2023 Jan 06.View Related Profiles. PMID: 36607535; DOI: 10.1007/s10557-022-07420-1;
  8. Moreira JD, Gower AC, Xue L, Alekseyev Y, Smith KK, Choi SH, Ayalon N, Farb MG, Tenan K, LeClerc A, Levy D, Benjamin EJ, Lenburg ME, Mitchell RN, Padera RF, Fetterman JL, Gopal DM. Systematic dissection, preservation, and multiomics in whole human and bovine hearts. Cardiovasc Pathol. 2023; 63:107495.View Related Profiles. PMID: 36334690; PMCID: PMC10031913; DOI: 10.1016/j.carpath.2022.107495;
  9. Alreshq R, Cozzolino M, Lilleness B, Pipilas A, Mendelson L, Joshi T, Muralidhar V, Guardino E, Berk JL, Siddiqi OK, Gopal DM, Sanchorawala V, Ruberg FL. Light Chain Testing Abnormalities Among Patients With Transthyretin Amyloid Cardiomyopathy Referred for Technetium-99m Pyrophosphate Imaging. Am J Cardiol. 2022 Oct 15; 181:105-112.View Related Profiles. PMID: 36028388; PMCID: PMC9675982; DOI: 10.1016/j.amjcard.2022.06.064;
  10. Schwartz B, Gjini P, Gopal DM, Fetterman JL. Inefficient Batteries in Heart Failure: Metabolic Bottlenecks Disrupting the Mitochondrial Ecosystem. JACC Basic Transl Sci. 2022 Nov; 7(11):1161-1179.View Related Profiles. PMID: 36687274; PMCID: PMC9849281; DOI: 10.1016/j.jacbts.2022.03.017;
Showing 10 of 41 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 41 publications over 17 distinct years, with a maximum of 7 publications in 2023


In addition to these self-described keywords below, a list of MeSH based concepts is available here.

diastolic dysfunction
left atrial function
cardiopulmonary exercise testing
pulmonary hypertension
metabolic syndrome

My research expertise is in developing the approach to clinical phenotyping of diastolic dysfunction in patients at high risk (Stage B) as well as with heart failure with preserved ejection fraction and pulmonary hypertension.

Available to Mentor as: (Review Mentor Role Definitions):
  • Research / Scholarly Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

75 E. Newton St Collamore Building
Boston MA 02118
Google Map

Gopal's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department